Catalyst Wire Dossier Catalyst Wire Dossier
EMA guidance · 2012-10-09

European Medicines Agency releases guideline on medicinal products for the treatment of schizophrenia

View source ↗

Summary

EMA releases a guideline outlining considerations for medicinal products intended to treat schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications